Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0350
+0.0010 (2.94%)
Aug 21, 2026, 4:06 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 11.88 million as of August 21, 2026. Its market cap has decreased by -4.18% in one year.
Market Cap
11.88M
Enterprise Value
11.53M
Revenue
2.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 11.88M, a decrease of -87.52%. That is a compound annual growth rate of -30.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 11.88M | 25.52% |
| Dec 31, 2025 | 9.47M | 54.80% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 25.56B |
| EBOS Group | 4.71B |
| Ryman Healthcare | 2.18B |
| Summerset Group Holdings | 1.89B |
| Pacific Edge | 310.46M |
| Green Cross Health | 277.60M |
| Radius Residential Care | 133.23M |
| Third Age Health Services | 46.59M |